Message from newly appointed outside directors

Outside Director (Independent Officer)
Yasuko Aitoku
Outside Director, Audit and Supervisory
Committee Member (Chair) (Independent Officer)
Etsuko Taniguchi
Outside Director, Audit and Supervisory
Committee Member (Independent Officer)
Yukiyo Nose

Working toward sustainable growth and strengthening trust building

Outside Director (Independent Officer): Yasuko Aitoku

Outside Director (Independent Officer) | Yasuko Aitoku

With experience gained at a R&D-focused global pharmaceutical company, I will fulfill my responsibilities as an independent officer to ensure that the Sawai Group plays its role in healthcare. I will also support the strengthening of governance systems from an external perspective to ensure the continuity of corporate activities as a pharmaceutical manufacturer that pursues scientific progress, maintains high ethical standards, and is trusted by patients, healthcare professionals, and society at large. Furthermore, I will discuss medium- to long-term solutions to concerns such as environmental considerations, drug price revisions, stable supply, and the increasingly sophisticated generic drug business with Board members to help establish a sustainable profit model.I hope to build greater momentum for transformation by leveraging the diversity of Sawai’s employees and visualizing the new corporate value that will be created.

Striving to establish a trusted corporate foundation

Outside Director, Audit and Supervisory Committee Member (Chair)(Independent Officer): Etsuko Taniguchi

Outside Director, Audit and Supervisory Committee Member | Etsuko Taniguchi

Based on my experience as a certified public accountant, I am committed to establishing a trusted corporate foundation, an underlying element of “Beyond 2027,” our medium-term business plan. To this end, I intend to fulfill my role as an outside director from a medium- to long-term perspective with a keen awareness of the Five Principles for Board of Directors to Enhance “Growth Power” as published by the Ministry of Economy, Trade and Industry, especially “while being mindful to avoid micromanagement...encourage the management team to ensure that the decision-making process and structure contribute to its timely and decisive decision-making.”In addition, I will monitor the progress of the Generic Drug Provider Evaluation System that we will be launching in earnest this fiscal year, seeing the deepening of this initiative as directly connected to the enhancement of the management base and the growth of the entire Group.

Contributing to greater corporate value from a global perspective

Outside Director, Audit and Supervisory Committee Member (Independent Officer): Yukiyo Nose

Outside Director, Audit and Supervisory Committee Member | Nose Yukiyo

My name is Yukiyo Nose, and I am a Japanese-American certified management consultant and physician.My desire is to bring a breath of fresh air to Japanese companies with a global mindset cultivated through 25 years of international experience in 50 countries around the world.I will strive to ensure my presence supports the future of the Group with more open perspectives and creative ideas. In addition to CSR and ESG initiatives, I would like to encourage both employees and their company to grow alongside each other and build a future-oriented corporate culture that is trusted by society.I will contribute to sustainable growth and strengthen governance, and take on the challenge of creating value for the 22nd century.

Message from newly appointed outside directors

Working toward sustainable growth and strengthening trust building

Striving to establish a trusted corporate foundation

Contributing to greater corporate value from a global perspective

Download all pages

Download in sections

Download separate volume of Financial section

Back issues